Drugs / SMZ
last change Jun 2026 re-read 2 minutes ago

SMZ

Developed for
pulmonary tuberculosis
Investigated by
First Affiliated Hospital of Zhejiang University

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05454345 Oct 2022 → Jun 2025 pulmonary tuberculosis First Affiliated Hospital of Zhejiang University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SMZ ClinicalTrials.gov intervention name — accepted as the source's own label NCT05454345